Clinical trial
Chlortalidone and Bumetanide in Advanced Chronic Kidney Disease: HEBE-CKD Trial
NCT03923933 is registered in ClinicalTrials.gov with Hospital General de México Dr. Eduardo Liceaga as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Chlortalidone and Bumetanide in Advanced Chronic Kidney Disease: HEBE-CKD Trial
- Lead sponsor
- Hospital General de México Dr. Eduardo Liceaga
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 18, 2019
- Completion date
- October 28, 2019
- Enrollment
- 34 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.